文献速递睡眠呼吸障碍肺栓塞与肺血管病慢阻肺

睡眠相关呼吸障碍与肺动脉高压

Sleep-related breathing disorders and pulmonary hypertension.
PubMed 文献 · Eur Respir J · 2021-01-05

本文综述睡眠相关呼吸障碍(SBDs)对肺动脉压的影响及其在肺动脉高压(PH)各临床分组中的意义。单纯阻塞性睡眠呼吸暂停综合征对肺动脉压影响小且临床意义未明,而肥胖低通气综合征或重叠综合征可导致严重PH,治疗SBDs可改善肺血流动力学。肺动脉高压或慢性血栓栓塞性肺动脉高压患者易合并SBDs,应高度怀疑并考虑持续气道正压或长期氧疗,但中枢性呼吸暂停不宜用适应性伺服通气。

要点

  • 单纯OSAS对肺动脉压影响小,临床意义未证实。
  • OHS或重叠综合征可致严重PH,治疗SBDs可改善肺血流动力学。
  • PAH/CTEPH患者应高度怀疑SBDs,OSAS者建议CPAP治疗。

核心结论

  • SBDs可影响睡眠及清醒状态下的肺动脉压,其临床意义因病因而异。
  • OHS或重叠综合征相关的夜间呼吸事件可导致严重PH,治疗SBDs对改善肺血流动力学至关重要。
  • PAH或CTEPH患者中SBDs常见,需高度怀疑并个体化治疗,但中枢性呼吸暂停慎用适应性伺服通气。

研究设计与样本

  • 本文为综述,检索范围未在摘要中明确报告。

主要发现

  • 单纯OSAS仅引起肺动脉压轻度升高,临床影响未证实。
  • OHS或重叠综合征(COPD合并OSA)的夜间呼吸事件促发常为严重的PH。
  • PAH或CTEPH患者睡眠中可观察到阻塞性/中枢性呼吸暂停及通气/灌注失衡加重。

关键数值与推荐

  • PAH或CTEPH患者合并OSAS时应鼓励CPAP治疗。
  • 存在孤立性夜间低氧血症应启动长期氧疗。
  • 慢性右心衰竭患者的中枢性呼吸暂停及Cheyne-Stokes呼吸不宜用适应性伺服通气,因潜在严重不良反应风险。

临床怎么用

  • 对OHS、重叠综合征及PAH/CTEPH患者应警惕SBDs并评估睡眠呼吸情况。
  • 确诊OSAS者可考虑CPAP,孤立夜间低氧者考虑长期氧疗。
  • 慢性右心衰竭患者的中枢性呼吸暂停避免使用适应性伺服通气。

局限性

  • PAH/CTEPH患者睡眠研究的精确指征及记录类型尚待明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sleep-related breathing disorders (SBDs) include obstructive apnoea, central apnoea and sleep-related hypoventilation. These nocturnal events have the potential to increase pulmonary arterial pressure (PAP) during sleep but also in the waking state. "Pure" obstructive sleep apnoea syndrome (OSAS) is responsible for a small increase in PAP whose clinical impact has not been demonstrated. By contrast, in obesity hypoventilation syndrome (OHS) or overlap syndrome (the association of chronic obstructive pulmonary disease (COPD) with obstructive sleep apnoea (OSA)), nocturnal respiratory events contribute to the development of pulmonary hypertension (PH), which is often severe. In the latter circumstances, treatment of SBDs is essential in order to improve pulmonary haemodynamics.Patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) are at risk of developing SBDs. Obstructive and central apnoea, as well as a worsening of ventilation-perfusion mismatch, can be observed during sleep. There should be a strong suspicion of SBDs in such a patient population; however, the precise indications for sleep studies and the type of recording remain to be specified. The diagnosis of OSAS in patients with PAH or CTEPH should encourage treatment with continuous positive airway pressure (CPAP). The presence of isolated nocturnal hypoxaemia should also prompt the initiation of long-term oxygen therapy. These treatments are likely to avoid worsening of PH; however, it is prudent not to treat central apnoea and Cheyne-Stokes respiration (CSR) with adaptive servo-ventilation in patients with chronic right-heart failure because of a potential risk of serious adverse effects from such treatment.In this review we will consider the current knowledge of the consequences of SBDs on pulmonary haemodynamics in patients with and without chronic respiratory disease (group 3 of the clinical classification of PH) and the effect of treatments of respiratory events during sleep on PH. The prevalence and consequences of SBDs in PAH and CTEPH (groups 1 and 4 of the clinical classification of PH, respectively), as well as therapeutic options, will also be discussed.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Adir Y, Humbert M, Chaouat A, et al. Sleep-related breathing disorders and pulmonary hypertension. Eur Respir J. 2021. PMID: 32747397. doi:10.1183/13993003.02258-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。